Purva Rathi

732 total citations
4 papers, 282 citations indexed

About

Purva Rathi is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Purva Rathi has authored 4 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Immunology and 1 paper in Molecular Biology. Recurrent topics in Purva Rathi's work include CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (2 papers). Purva Rathi is often cited by papers focused on CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (2 papers). Purva Rathi collaborates with scholars based in United States. Purva Rathi's co-authors include Andras Heczey, Linjie Guo, Leonid S. Metelitsa, Amy N. Courtney, Julien Fleurence, Maksim Mamonkin, Rahamthulla S. Shaik, Thao P. Nguyen, Julien Balzeau and Meng‐Fen Wu and has published in prestigious journals such as Journal of Clinical Oncology, Human Gene Therapy and Cancer Immunology Research.

In The Last Decade

Purva Rathi

4 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Purva Rathi United States	4	245	123	86	67	63	4	282
Roseanna M. Petrovic United Kingdom	5	238 1.0×	104 0.8×	76 0.9×	86 1.3×	65 1.0×	8	282
Sean C. Dougherty United States	5	292 1.2×	126 1.0×	118 1.4×	68 1.0×	80 1.3×	14	341
Earle O. Assanah United States	2	322 1.3×	128 1.0×	54 0.6×	123 1.8×	95 1.5×	2	349
Su Jingwen China	6	353 1.4×	230 1.9×	109 1.3×	107 1.6×	70 1.1×	7	430
Aodrenn Spill Switzerland	4	241 1.0×	137 1.1×	78 0.9×	68 1.0×	46 0.7×	6	300
Manuel Wiesinger Germany	9	226 0.9×	189 1.5×	104 1.2×	39 0.6×	96 1.5×	11	335
Leena Halim United Kingdom	5	246 1.0×	200 1.6×	77 0.9×	81 1.2×	74 1.2×	7	360
Youguo Long China	8	209 0.9×	125 1.0×	69 0.8×	46 0.7×	53 0.8×	10	243
Donghua Shi China	5	254 1.0×	158 1.3×	68 0.8×	55 0.8×	42 0.7×	7	353
Takeya Masubuchi United States	6	186 0.8×	180 1.5×	99 1.2×	50 0.7×	30 0.5×	8	315

Countries citing papers authored by Purva Rathi

Since Specialization

Citations

This map shows the geographic impact of Purva Rathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Purva Rathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Purva Rathi more than expected).

Fields of papers citing papers by Purva Rathi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Purva Rathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Purva Rathi. The network helps show where Purva Rathi may publish in the future.

Co-authorship network of co-authors of Purva Rathi

This figure shows the co-authorship network connecting the top 25 collaborators of Purva Rathi. A scholar is included among the top collaborators of Purva Rathi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Purva Rathi. Purva Rathi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Shaik, Rahamthulla S., Purva Rathi, Amy N. Courtney, et al.. (2022). Glypican-3-specific CAR-NKT cells overexpressing BATF3 mediate potent antitumor activity against hepatocellular carcinoma.. Journal of Clinical Oncology. 40(16_suppl). e14521–e14521. 3 indexed citations

2.

Rathi, Purva, Linjie Guo, Amy N. Courtney, et al.. (2020). Glypican-3–Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma. Cancer Immunology Research. 8(3). 309–320. 193 indexed citations

3.

Rathi, Purva, Linjie Guo, Wenpeng Li, et al.. (2019). A phase I clinical trial using armored GPC3 CAR T cells for children with relapsed/refractory liver tumors.. Journal of Clinical Oncology. 37(15_suppl). TPS2647–TPS2647. 8 indexed citations

4.

Li, Wenpeng, Linjie Guo, Purva Rathi, et al.. (2016). Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity. Human Gene Therapy. 28(5). 437–448. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact